Searching the grey literature to access research on illicit drug use, HIV and viral hepatitis: An update
Resource Type:
This technical report is an update of the 2016 technical
Technical Reports
Viability of an Early Warning System (ViEWS) Study: Final Report
Resource Type:
There is a recognised opportunity for more systematic and timely triangulation of existing data to rapidly assess and identify emerging illicit drug trends in Australia.
A protocol for the extension of the Australian Parental Supply of Alcohol Longitudinal Study (APSALS)
Resource Type:
NDARC Technical Report No. 340
A systematic review of the global prevalence of prescription opioid non-medical use with an estimate of prescription opioid dependence
Resource Type:
Trends in the nonmedical use of prescription opioids (NMUPO) have been rising in the past few decades, causing increases in morbidity and mortality due to prescription opioids (POs).
Co-morbid mental and substance use disorders – a meta-review of treatment effectiveness
Resource Type:
Comorbidity of mental and substance use disorders is common, debilitating and associated with poor clinical and functional outcomes.
Supported accommodation services for people released from custody: A systematic review to inform the development of the Rainbow Lodge Program
Resource Type:
Executive Summary
Searching the grey literature to access research on illicit drug use, HIV and viral hepatitis: A resource to identify drug-related databases and websites
Resource Type:
What is grey literature?
Patient motivations, perceptions and experiences of opioid substitution therapy in prison
Resource Type:
Executive Summary
Understanding the health and service needs of diverse populations of pharmaceutical opioid users: Cohort studies of dependent users in treatment, and people who inject drugs
Resource Type:
NDARC Technical Report Number 331 (2015)
Medicinal Cannabis in Australia- Framing the Regulatory Options
Resource Type:
The aim of this paper is to explore and provide a framework for discussion around the regulatory issues, notably access and supply of medicinal cannabis.